购物车
您的购物车当前为空
Anti-APOB Monoclonal Antibody (9Q614) 是一种 Mouse 抗体,靶向 APOB。Anti-APOB Monoclonal Antibody (9Q614) 可用于 IF,FCM。
别名 LDLCQ4, FLDB
Anti-APOB Monoclonal Antibody (9Q614) 是一种 Mouse 抗体,靶向 APOB。Anti-APOB Monoclonal Antibody (9Q614) 可用于 IF,FCM。

TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | Anti-APOB Monoclonal Antibody (9Q614) is a Mouse antibody targeting APOB. Anti-APOB Monoclonal Antibody (9Q614) can be used in IF,FCM. |
| 别名 | LDLCQ4, FLDB |
| Ig Type | IgG1 |
| 克隆号 | 9Q614 |
| 反应种属 | Human |
| 应用 | IFFCM |
| 推荐剂量 | IF: 1/200-1/1000; FCM: 1/200-1/400 |
| 抗体种类 | Monoclonal |
| 宿主来源 | Mouse |
| 构建方式 | Hybridoma Monoclonal Antibody |
| 纯化方式 | Purified by protein A or protein G |
| 性状 | Liquid |
| 缓冲液 | PBS with 0.05% sodium azide |
| 浓度 | 1 mg/ml |
| 研究背景 | This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. |
| 偶联 | Unconjugated |
| 免疫原 | Purified recombinant fragment of human ApoB expressed in E. Coli. |
| 抗原种属 | Human |
| 基因名称 | APOB |
| 基因ID | |
| 蛋白名称 | Apolipoprotein B-100 |
| Uniprot ID |
| 储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| 运输方式 | Shipping with blue ice. |